Kyrklund C - Search Results

1

Plasma concentrations of active simvastatin acid are increased by gemfibrozil.

Backman JT, Kyrklund C, Kivistö KT, Wang JS, Neuvonen PJ. Backman JT, et al. Among authors: kyrklund c. Clin Pharmacol Ther. 2000 Aug;68(2):122-9. doi: 10.1067/mcp.2000.108507. Clin Pharmacol Ther. 2000. PMID: 10976543 Clinical Trial.

2

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate.

Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ. Kyrklund C, et al. Clin Pharmacol Ther. 2001 May;69(5):340-5. doi: 10.1067/mcp.2001.115542. Clin Pharmacol Ther. 2001. PMID: 11372002 Clinical Trial.

3

Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.

Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ. Kyrklund C, et al. Clin Pharmacol Ther. 2000 Dec;68(6):592-7. doi: 10.1067/mcp.2000.111414. Clin Pharmacol Ther. 2000. PMID: 11180018 Clinical Trial.

4

Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.

Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. Kyrklund C, et al. Br J Clin Pharmacol. 2004 Feb;57(2):181-7. doi: 10.1046/j.1365-2125.2003.01972.x. Br J Clin Pharmacol. 2004. PMID: 14748817 Free PMC article. Clinical Trial.

5

Gemfibrozil greatly increases plasma concentrations of cerivastatin.

Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ. Backman JT, et al. Among authors: kyrklund c. Clin Pharmacol Ther. 2002 Dec;72(6):685-91. doi: 10.1067/mcp.2002.128469. Clin Pharmacol Ther. 2002. PMID: 12496749 Clinical Trial.

6

Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.

Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. Kyrklund C, et al. Clin Pharmacol Ther. 2003 Jun;73(6):538-44. doi: 10.1016/S0009-9236(03)00052-3. Clin Pharmacol Ther. 2003. PMID: 12811363 Clinical Trial.

7

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman JT, Kerb R, Schwab M, Neuvonen PJ, Eichelbaum M, Kivistö KT. Niemi M, et al. Among authors: kyrklund c. Pharmacogenetics. 2004 Jul;14(7):429-40. doi: 10.1097/01.fpc.0000114750.08559.32. Pharmacogenetics. 2004. PMID: 15226675

8

Allergic contact dermatitis caused by transdermal buprenorphine.

Kyrklund C, Hyry H, Alanko K. Kyrklund C, et al. Contact Dermatitis. 2013 Jul;69(1):60-1. doi: 10.1111/cod.12051. Contact Dermatitis. 2013. PMID: 23782362 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results